Administrative Claims Analysis of Utilization and Costs of Care in Health Plan Members With Atopic Dermatitis Who Had Prior Use of a Topical Corticosteroid and Who Initiate Therapy With Pimecrolimus or Tacrolimus

BACKGROUND: In the United States, pimecrolimus cream and tacrolimus ointment are approved as second-line therapy for short-term and intermittent noncontinuous long-term treatment of atopic dermatitis (AD) in nonimmunocompromised patients aged 2 years or older who have failed to respond adequately to...

Descripción completa

Detalles Bibliográficos
Autores principales: Delea, Thomas E., Gokhale, Manjusha, Makin, Charles, Hussein, Mohamed A., Vanderpoel, Julie, Sandman, Timothy, Chang, Jane, Sung, Jennifer, Pinkston, Paul, Gause, Douglas, Jackson, J. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2007
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437606/
https://www.ncbi.nlm.nih.gov/pubmed/17506601
http://dx.doi.org/10.18553/jmcp.2007.13.4.349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437606/
https://www.ncbi.nlm.nih.gov/pubmed/17506601
http://dx.doi.org/10.18553/jmcp.2007.13.4.349

Ejemplares similares